These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22613071)

  • 1. Role of the laboratory in monitoring patients receiving dual antiplatelet therapy.
    Vidali M; Rolla R; Parrella M; Cassani C; Manzini M; Portalupi MR; Serino R; Prando MD; Bellomo G; Pergolini P
    Int J Lab Hematol; 2012 Oct; 34(5):484-94. PubMed ID: 22613071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
    Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
    Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance.
    Tsantes A; Ikonomidis I; Papadakis I; Kottaridi C; Tsante A; Kalamara E; Kardoulaki A; Kopterides P; Kapsimali V; Karakitsos P; Lekakis J; Travlou A
    Platelets; 2012; 23(6):481-9. PubMed ID: 22646492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function.
    Gori AM; Marcucci R; Paniccia R; Giusti B; Fedi S; Antonucci E; Buonamici P; Antoniucci D; Gensini GF; Abbate R
    Thromb Haemost; 2008 Dec; 100(6):1136-45. PubMed ID: 19132241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Thromb Haemost; 2009 Feb; 101(2):333-9. PubMed ID: 19190818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
    Eshtehardi P; Windecker S; Cook S; Billinger M; Togni M; Garachemani A; Meier B; Hess OM; Wenaweser P
    Am Heart J; 2010 May; 159(5):891-898.e1. PubMed ID: 20435201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
    Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
    Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation and the risk of stent thrombosis or bleeding in elective percutaneous coronary intervention patients.
    Kukula K; Klopotowski M; Kunicki P; Jamiolkowski J; Debski A; Bekta P; Chmielak Z; Witkowski A
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):383-388. PubMed ID: 28009648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease.
    Mueller T; Dieplinger B; Poelz W; Haltmayer M
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):652-9. PubMed ID: 18805846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay.
    Siller-Matula JM; Christ G; Lang IM; Delle-Karth G; Huber K; Jilma B
    J Thromb Haemost; 2010 Feb; 8(2):351-9. PubMed ID: 19943879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
    Moerenhout CM; Claeys MJ; Haine S; Miljoen H; Bosmans JM; Vertessen F; Kluppels K; Van der Planken M; Vrints CJ
    Am Heart J; 2010 Mar; 159(3):434-8. PubMed ID: 20211306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?
    von Lewinski F; Riggert J; Paulus W
    J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel cessation triggers aspirin rebound in patients with coronary stent.
    Djukanovic N; Todorovic Z; Obradovic S; Njegomirovic S; Zamaklar-Trifunovic D; Protić D; Ostojic M
    J Clin Pharm Ther; 2014 Feb; 39(1):69-72. PubMed ID: 24286218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
    Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
    J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):532-9. PubMed ID: 20729752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.